How To Do It: Get patients' consent to enter clinical trials

Authors:

Abstract
Study design Before starting to recruit patients you should be satisfied that the study itself is ethical. Anyone designing a study should consider the issue of patient consent at the outset. You must obtain approval from your research ethics committee for any clinical trial involving patients, and the committee should review any information and consent forms given to patients. As consent is about asking patients to make a choice, patients should perhaps be consulted about trial design. Consent can be regarded as a reasonable choice only if the patient's aspirations match those of the study.6 This is particularly important for patients with life threatening illnesses, when choices between quantity and quality of life may be more affected by personal circumstances than medical considerations. In the United States organisations such as the National Breast Cancer Coalition campaign for patients to participate more in research. In Britain such advocacy movements are less common, but some well established self help groups for patients could be consulted about clinical trials. To explain a trial clearly the investigator must understand the aims of the trial and exactly how it will be conducted. One study of the quality of informed consent found that patients attending centres that had not participated in designing the study considered that they received poorer information than those recruited by investigators who had been active in the study from the start.7

This publication has 33 references indexed in Scilit: